title: Two cases of severe angio-oedema and rationale for their response to icatibant.
authors.affiliation: Morehouse School of Medicine, Atlanta, Georgia, USA.
authors.forename: Oluwaseun O
authors.initials: OO
authors.lastname: Akinduro
authors.affiliation: Emory School of Medicine, Atlanta, Georgia, USA.
authors.forename: Vishal
authors.initials: V
authors.lastname: Patel
authors.affiliation: Department of Neurology, Emory School of Medicine, Atlanta, Georgia, USA.
authors.forename: Tommy
authors.initials: T
authors.lastname: Thomas
authors.affiliation: Emory University, Atlanta, Georgia, USA.
authors.forename: Faiz U
authors.initials: FU
authors.lastname: Ahmad
mesh_terms: D000328:Adult; D000368:Aged; D000799:Angioedema / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001920:Bradykinin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D065094:Bradykinin B2 Receptor Antagonists / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008046:Lip / Q000473:pathology; D008297:Male; D014059:Tongue / Q000473:pathology
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000894:Anti-Inflammatory Agents, Non-Steroidal; D065094:Bradykinin B2 Receptor Antagonists; C065679:icatibant; D001920:Bradykinin